Commitments and Contingencies |
12 Months Ended | ||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Dec. 31, 2021 | |||||||||||||||||||||||
Commitments and Contingencies [Abstract] | |||||||||||||||||||||||
Commitments and Contingencies |
Lease Commitments
The Company has one operating lease for its office
space which was amended effective January 1, 2019 for a term of 38 months with no residual value guarantees or material restrictive
covenants. The amended lease provided for free rent for the first two months of the lease and continues the security deposit of $6,000. In addition to base rental payments included in the contractual obligations table below, the Company is responsible for our pro-rata share of the
operating expenses for the building. Our lease cost for the years ended December 31, 2021 and 2020 was $44,000 and $44,000 and is included in general and administrative expenses. As of December 31, 2021, the right to use lease asset consisted of $7,000 and is included in The Company renewed its existing office space lease effective in February 2022 for 38 months at substantially
the same terms.
.
Also, at December 31, 2021, current lease liability of $8,000 is included in .Maturity of operating lease as of December 31, 2021 in thousands:
The discount rate used in calculating the present value of the lease payments was 11.04%.
Legal Proceedings
The Company records accruals for such contingencies to the extent that the Company concludes that their occurrence is probable and the related damages are estimable.
There are no pending legal proceedings.
Clinical Trial and Research Contingencies
The Company has entered into agreements with contractors for research and development activities to further its product candidates. The contracts generally may be
canceled at any time by providing thirty days’ notice.
|